Florida Health Daily
SEE OTHER BRANDS

Your best source on healthcare and wellness news from Florida

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on March 13, 2025

Sutro Biopharma Announces Strategic Portfolio Review Resulting in the Prioritization of its Next-Generation ADC Pipeline

Sutro Biopharma Announces Strategic Portfolio Review Resulting in the Prioritization of its Next-Generation ADC Pipeline

– Sutro will rapidly advance next-generation exatecan and dual-payload ADC programs; luveltamab tazevibulin development to be deprioritized as Sutro continues to seek a partner – – Three INDs for wholly-owned programs expected in the next 3 years, …

Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

-  Company is applying its T cell-selective lipid nanoparticle to develop siRNA therapeutics for T cell-driven autoimmune diseases -  Lead target and indication to be announced MY 2025 -  Cash balance of $185.2 million expected to fund operations into 2H …

The Joint Corp. Reports Fourth Quarter and Year-end 2024 Financial Results

The Joint Corp. Reports Fourth Quarter and Year-end 2024 Financial Results

- Grew revenue from continuing operations 10% annually and 14% quarterly compared to the same period in 2023 - - Increased system-wide sales 9% for both the year and Q4 2024 – SCOTTSDALE, Ariz., March 13, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: …

Evoke Pharma, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Evoke Pharma, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Q4 2024 revenue increased 24.6% over Q3 2024; Full-year 2024 revenue grew 97.8% year-over-year Strong growth in key commercial metrics, including prescriber base, fill rates, and patient enrollments Secured $14.3 million net proceeds in financings, …

Allogene Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update

Allogene Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update

Momentum Builds Across Programs with Key Data Milestones Expected in 2025 Cemacabtagene Ansegedleucel (Cema-Cel): First-Line (1L) Consolidation in Large B-Cell Lymphoma (LBCL) Ongoing Pivotal Phase 2 ALPHA3 Trial Advancing with Site Activation and Patient …

Lyra Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Lyra Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Company continues to focus on upcoming results from ENLIGHTEN 2 pivotal Phase 3 trial in CRS patients, expected in 2Q 2025 In parallel, the Company continues to analyze data and explore opportunities for LYR-210 in CRS patient cohort with nasal polyps …

aTyr Pharma Announces Fourth Quarter and Full Year 2024 Results and Provides Corporate Update

aTyr Pharma Announces Fourth Quarter and Full Year 2024 Results and Provides Corporate Update

Topline data from Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis expected in the third quarter of 2025. Fourth positive DSMB review for efzofitimod in Phase 3 EFZO-FIT™ study reinforces its favorable safety profile. Publication in Science …

Senti Bio Appoints Feng Hsiung to Board of Directors

Senti Bio Appoints Feng Hsiung to Board of Directors

SOUTH SAN FRANCISCO, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio,” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene …

Nurix Therapeutics Appoints Drug Development Expert Roy D. Baynes, MB.Bch., M.Med., Ph.D., to Its Board of Directors

Nurix Therapeutics Appoints Drug Development Expert Roy D. Baynes, MB.Bch., M.Med., Ph.D., to Its Board of Directors

SAN FRANCISCO, March 13, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, announced today the …

Dr. Michael L. Goldberg Awarded As 2024 FL Top Doc

Dr. Michael L. Goldberg Awarded As 2024 FL Top Doc

FL Top Docs has reviewed and approved Dr. Michael L. Goldberg of MedVantage Primary Care for 2024. BOYNTON BEACH, FL, UNITED STATES, March 13, 2025 /⁨EINPresswire.com⁩/ -- FL Top Docs has reviewed and approved Dr. Michael L. Goldberg of MedVantage …

HealthPRO Canada Recognized As One Of 2025 Best Workplaces™ Led by Women

HealthPRO Canada Recognized As One Of 2025 Best Workplaces™ Led by Women

Oakville, ON, March 13, 2025 (GLOBE NEWSWIRE) -- HealthPRO Canada, Canada’s national group contracting provider for healthcare, is proud to announce it has been named as one of the 2025 Best Workplaces™ Led by Women. As a part of their Lead. Inspire. …

Advocates Rallied in Record Numbers for Call-on Congress 2025

Advocates Rallied in Record Numbers for Call-on Congress 2025

Washington D.C., March 13, 2025 (GLOBE NEWSWIRE) -- Fight Colorectal Cancer (Fight CRC), the nation’s leading advocacy organization dedicated to ending colorectal cancer, brought together more than 300 survivors, caregivers, and loved ones for the 19th …

Virbac: 2024 Annual results

Virbac: 2024 Annual results

Very strong revenues increase of 13.6% at constant exchange rates, driven by: dynamic organic growth (+7.5%) strategic contribution of our acquisitions (+6.1%) 2024 operating income2 at an all-time high of 16.6% of revenues (16.0% excluding acquisitions) …

VIRBAC: Résultats 2024

VIRBAC: Résultats 2024

Chiffre d’affaires en très forte progression de 13,6% à taux de change constant tirée par : une croissance organique dynamique (+7,5%) l’apport stratégique de nos acquisitions (+6,1%) Un résultat opérationnel2 2024 à un niveau historique de 16,6% du …

nuEra Cannabis Expands Medical Cannabis Access for Women’s Health

nuEra Cannabis Expands Medical Cannabis Access for Women’s Health

CHICAGO, March 13, 2025 (GLOBE NEWSWIRE) -- This Women’s Month, nuEra Cannabis is championing expanded access to medical cannabis for women by raising awareness about newly added qualifying conditions in Illinois’ medical cannabis program. The Illinois …

PALTmed & LTC ACO Launch Value-Based Care Joint Alliance

PALTmed & LTC ACO Launch Value-Based Care Joint Alliance

KENNETT SQUARE, Pa., March 13, 2025 (GLOBE NEWSWIRE) -- Post-Acute and Long-Term Care Medical Association (PALTmed), the leading medical specialty society dedicated to supporting clinicians in post-acute and long-term care (PALTC) settings, and LTC ACO, …

MEDIA ADVISORY: Ontario Health Coalition shocked and disappointed with court rulings in Bill 7 Charter Challenge and Orchard Villa case; vows to continue the fight to protect the rights of the elderly

MEDIA ADVISORY: Ontario Health Coalition shocked and disappointed with court rulings in Bill 7 Charter Challenge and Orchard Villa case; vows to continue the fight to protect the rights of the elderly

TORONTO, March 13, 2025 (GLOBE NEWSWIRE) -- In a press conference this morning, the Ontario Health Coalition responded to court rulings in two cases impacting thousands of elderly hospital patients and long-term care residents in Ontario. The first case, …

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 13 March 2025 at 16.45 EET                        Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has …

Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.)

Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.)

ORION OYJ         PÖRSSITIEDOTE / SUURIMMAT OSAKKEENOMISTAJAT -TIEDOTE         13.3.2025 KLO 16.45          Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.) Orion Oyj on saanut Arvopaperimarkkinalain 9. luvun 5 §:n …

Academy of Nutrition and Dietetics Celebrates Nutrition and Dietetics Technician, Registered Day, March 13, During National Nutrition Month®

Academy of Nutrition and Dietetics Celebrates Nutrition and Dietetics Technician, Registered Day, March 13, During National Nutrition Month®

Chicago, March 13, 2025 (GLOBE NEWSWIRE) -- Today, March 13, the Academy of Nutrition and Dietetics is proud to shine a spotlight on the important work of nutrition and dietetics technician, registered (NDTRs) in celebration of Nutrition and Dietetics …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service